Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) Return on equity
Veeva Systems Inc.'s return on equity over the twelve months to 31 July 2026 was 14.4%, up 0.5 percentage points from fiscal 2026 (13.9%). Over the past ten years it has ranged from 11.7% (fiscal 2015) to 21.4% (fiscal 2019); the current reading is higher than 50% of that period. That is above the Health Information Services industry median of −6.91% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 13.9% | 0.30 |
| FY2025 | 13.6% | 1.05 |
| FY2024 | 12.6% | (2.14) |
| FY2023 | 14.7% | (1.79) |
| FY2022 | 16.5% | (2.82) |
| FY2021 | 19.3% | (1.41) |
| FY2020 | 20.7% | (0.70) |
| FY2019 | 21.4% | 2.04 |
| FY2018 | 19.4% | 6.00 |
| FY2017 | 13.4% | 1.47 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| HNGE Hinge Health Inc. compare | 41.4% |
| HTFL Heartflow, Inc. compare | 38.5% |
| BTSG BrightSpring Health Services, Inc. compare | 19.3% |
| DOCS Doximity, Inc. compare | 17.2% |
| VEEV Veeva Systems Inc. | 14.4% |
| HQY HealthEquity, Inc. compare | 11.4% |
| WAY Waystar Holding Corp. compare | 3.77% |
| TXG 10x Genomics compare | −9.40% |
| TEM Tempus AI, Inc. compare | −67.4% |
| Health Information Services industry median | −6.91% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement